Home/Filings/4/0001209191-23-001016
4//SEC Filing

Daniels Kevin 4

Accession 0001209191-23-001016

CIK 0001000229other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:50 PM ET

Size

8.5 KB

Accession

0001209191-23-001016

Insider Transaction Report

Form 4
Period: 2022-12-31
Daniels Kevin
CAO & Treasurer
Transactions
  • Tax Payment

    Common Shares

    2022-12-31$20.27/sh2,361$47,8578,663 total
  • Exercise/Conversion

    Common Shares

    2022-12-31+6,00011,024 total
  • Exercise/Conversion

    Performance Shares

    2022-12-316,0000 total
    Exercise: $0.00Common Shares (6,000 underlying)
Footnotes (1)
  • [F1]These shares were awarded as restricted performance shares in February 2020, as disclosed in the Reporting Person's Form 4 filing on February 12, 2020. All requirements for 100% vesting have been met and thus the restricted shares vested on December 31, 2022 at the conclusion of the performance period.

Issuer

CORE LABORATORIES N V

CIK 0001000229

Entity typeother

Related Parties

1
  • filerCIK 0001740507

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:50 PM ET
Size
8.5 KB